Literature DB >> 2197296

A computerized approach to cognitive behavioural assessment: an introduction to CBA-2.0 primary scales.

G Bertolotti1, A M Zotti, P Michielin, G Vidotto, E Sanavio.   

Abstract

The Cognitive Behavioural Assessment-2.0 (CBA-2.0) Primary Scales is an automated assessment package investigating the cognitive-verbal response system. It consists of: (1) self-reports and questionnaires aimed at identifying and specifying patients' problems; (2) a group of programs and logical rules, implemented on personal computers, providing an editor with items, questionnaire scoring and an analysis of responses; (3) an intelligent program which analyzes the responses emerging from the questionnaires and forms hypotheses for the selection of Secondary Scales and for further assessment. The package is part of a research project aimed at reducing part of the decision-making process to an operational language and simulating behavioral therapists decisions in cases of clinical assessment.

Entities:  

Mesh:

Year:  1990        PMID: 2197296     DOI: 10.1016/0005-7916(90)90045-m

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  14 in total

1.  Update on the family strain questionnaire: a tool for the general screening of caregiving-related problems.

Authors:  Silvia Rossi Ferrario; Paola Baiardi; Anna Maria Zotti
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

2.  ATS-PD: An Adaptive Testing System for Psychological Disorders.

Authors:  Ivan Donadello; Andrea Spoto; Francesco Sambo; Silvana Badaloni; Umberto Granziol; Giulio Vidotto
Journal:  Educ Psychol Meas       Date:  2016-06-15       Impact factor: 2.821

3.  Orthorexia nervosa: relationship with obsessive-compulsive symptoms, disordered eating patterns and body uneasiness among Italian university students.

Authors:  Anna Brytek-Matera; Maria Luisa Fonte; Eleonora Poggiogalle; Lorenzo Maria Donini; Hellas Cena
Journal:  Eat Weight Disord       Date:  2017-08-24       Impact factor: 4.652

4.  Does job satisfaction predict early return to work after coronary angioplasty or cardiac surgery?

Authors:  Elena Fiabane; Piergiorgio Argentero; Giuseppe Calsamiglia; Stefano M Candura; Ines Giorgi; Fabrizio Scafa; Reiner Rugulies
Journal:  Int Arch Occup Environ Health       Date:  2012-06-09       Impact factor: 3.015

5.  New Perspectives in the Adaptive Assessment of Depression: The ATS-PD Version of the QuEDS.

Authors:  Andrea Spoto; Francesca Serra; Ivan Donadello; Umberto Granziol; Giulio Vidotto
Journal:  Front Psychol       Date:  2018-07-06

6.  Depressive symptoms and cardiovascular reactivity to laboratory behavioral stress.

Authors:  Jeffrey L Kibler; Mindy Ma
Journal:  Int J Behav Med       Date:  2004

7.  Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores.

Authors:  Giorgio Bertolotti; Loretta Moroni; Roberto Burro; Antonio Spanevello; Roberto Fe Pedretti; Giandomenico Giorgetti
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-12       Impact factor: 2.570

8.  Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.

Authors:  Cristina Stasi; Massimo Bellini; Dario Gambaccini; Emiliano Duranti; Nicola de Bortoli; Bernardo Fani; Eleonora Albano; Salvatore Russo; Isabella Sudano; Giacomo Laffi; Stefano Taddei; Santino Marchi; Rosa Maria Bruno
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

9.  Improving Major Depressive Episode Assessment: A New Tool Developed by Formal Psychological Assessment.

Authors:  Francesca Serra; Andrea Spoto; Marta Ghisi; Giulio Vidotto
Journal:  Front Psychol       Date:  2017-02-17

10.  Metric qualities of the cognitive behavioral assessment for outcome evaluation to estimate psychological treatment effects.

Authors:  Giorgio Bertolotti; Paolo Michielin; Giulio Vidotto; Ezio Sanavio; Gioia Bottesi; Ornella Bettinardi; Anna Maria Zotti
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-24       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.